High demand for new RSV treatment for infants outpaces national supply

Respiratory syncytial virus leads to as many as 80,000 hospitalizations and 300 deaths per year among children under 5, and is the leading cause of hospitalization for infants under 1 year old. Dr. Cline Gounder, an epidemiologist and senior fellow at KFF, joins Amna Nawaz to discuss the impact of a shortage of drugs to

Respiratory syncytial virus leads to as many as 80,000 hospitalizations and 300 deaths per year among children under 5, and is the leading cause of hospitalization for infants under 1 year old. Dr. Céline Gounder, an epidemiologist and senior fellow at KFF, joins Amna Nawaz to discuss the impact of a shortage of drugs to treat RSV.

ncG1vNJzZmivp6x7sa7SZ6arn1%2Bjsri%2Fx6isq2ejnby4e8einqFllJq6orrDZp2oql2jsrh50aytZqyimq61ucSnq2aen6d6rLXDrGSoraSlrqSx0malmqyZpLuiuIysrKmonK4%3D

 Share!